These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12940929)

  • 21. Adequacy of nutritional intake in a Canadian population of patients with Crohn's disease.
    Aghdassi E; Wendland BE; Stapleton M; Raman M; Allard JP
    J Am Diet Assoc; 2007 Sep; 107(9):1575-80. PubMed ID: 17761234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome.
    Royall D; Jeejeebhoy KN; Baker JP; Allard JP; Habal FM; Cunnane SC; Greenberg GR
    Gut; 1994 Jun; 35(6):783-7. PubMed ID: 8020806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty Acids as Useful Serological Markers for Crohn's Disease.
    Ito Z; Uchiyama K; Odahara S; Takami S; Saito K; Kobayashi H; Koido S; Kubota T; Ohkusa T; Saruta M
    Dig Dis; 2018; 36(3):209-217. PubMed ID: 29275413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
    Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biology of essential fatty acids (EFA)].
    Dobryniewski J; Szajda SD; Waszkiewicz N; Zwierz K
    Przegl Lek; 2007; 64(2):91-9. PubMed ID: 17892040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease.
    Zoli G; Carè M; Parazza M; Spanò C; Biagi PL; Bernardi M; Gasbarrini G
    Aliment Pharmacol Ther; 1997 Aug; 11(4):735-40. PubMed ID: 9305483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrient Intake of Crohn's Patients: Is There Consistency between Crohn's Disease Activity Index, Subjective Global Assessment and Body Mass Index?
    İnanç N; Fırat YY; Başmısırlı E; Çapar AG
    Iran J Public Health; 2021 Dec; 50(12):2584-2592. PubMed ID: 36317031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dietary intake in Crohn's disease: results of a prospective comparative study].
    Serghini M; Wechtati M; Boubaker J; Filali A
    Tunis Med; 2014; 92(8-9):551-5. PubMed ID: 25815541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of essential fatty acid deficiency in patients with chronic gastrointestinal disorders.
    Siguel EN; Lerman RH
    Metabolism; 1996 Jan; 45(1):12-23. PubMed ID: 8544768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered subjective appetite parameters in Crohn's disease patients.
    Bannerman E; Davidson I; Conway C; Culley D; Aldhous MC; Ghosh S
    Clin Nutr; 2001 Oct; 20(5):399-405. PubMed ID: 11534934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The essential fatty acids.
    Sardesai VM
    Nutr Clin Pract; 1992 Aug; 7(4):179-86. PubMed ID: 1294887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease.
    Khoshoo V; Reifen R; Neuman MG; Griffiths A; Pencharz PB
    JPEN J Parenter Enteral Nutr; 1996; 20(6):401-5. PubMed ID: 8950740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD.
    Westcott ED; Mattacks CA; Windsor AC; Knight SC; Pond CM
    Ann N Y Acad Sci; 2006 Aug; 1072():395-400. PubMed ID: 17057221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.
    Azcue M; Rashid M; Griffiths A; Pencharz PB
    Gut; 1997 Aug; 41(2):203-8. PubMed ID: 9301499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune activation and nutritional status in adult Crohn's disease patients.
    Reimund JM; Arondel Y; Escalin G; Finck G; Baumann R; Duclos B
    Dig Liver Dis; 2005 Jun; 37(6):424-31. PubMed ID: 15893281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whey and soy protein supplements changes body composition in patients with Crohn's disease undergoing azathioprine and anti-TNF-alpha therapy.
    Machado JF; Oya V; Coy CS; Morcillo AM; Severino SD; Wu C; Sgarbieri VC; Vilela MM
    Nutr Hosp; 2015 Apr; 31(4):1603-10. PubMed ID: 25795947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essential fatty acid deficiency in well nourished young cystic fibrosis patients.
    Roulet M; Frascarolo P; Rappaz I; Pilet M
    Eur J Pediatr; 1997 Dec; 156(12):952-6. PubMed ID: 9453380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential fatty acids in erythrocyte phospholipids during pregnancy and at delivery in mothers and their neonates: comparison with plasma phospholipids.
    Vlaardingerbroek H; Hornstra G
    Prostaglandins Leukot Essent Fatty Acids; 2004 Dec; 71(6):363-74. PubMed ID: 15519495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired essential fatty acid metabolism in latent tetany.
    Galland L
    Magnesium; 1985; 4(5-6):333-8. PubMed ID: 3010003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.